Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;1(1):200-208.
doi: 10.3892/mco.2012.31. Epub 2012 Oct 2.

Effects of systematic rehabilitation programs on quality of life in patients undergoing lung resection

Affiliations

Effects of systematic rehabilitation programs on quality of life in patients undergoing lung resection

Xu-Hong Li et al. Mol Clin Oncol. 2013 Jan.

Abstract

The aim of this study was to investigate the effects of systematic rehabilitation programs on the quality of life (QOL) in patients undergoing lung resection of malignant lung lesions. In this prospective population-based cohort study, QOL in patients prior to, as well as 3 and 6 months after surgery, was investigated. Using a single-group design, 48 patients (7 females and 41 males) with suspected operable lung cancer were included in this study. The demographic characteristics and the clinical history of the patients were recorded. QOL [assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 3.0 (EORTC QLQ-C30)] was evaluated at baseline (immediately before), and 3 and 6 months after surgical resection. The systematic rehabilitation program, including breathing control, breathing exercises, relaxation training, upper and lower extremity exercises, mobilization and additional incorporating physiotherapy programs, was designed to meet each patient's individual needs. The χ2 and Fisher's tests showed no statistically significant difference in the two groups in terms of age, gender, behavior, clinical stage, adjuvant therapy and Karnofsky scores. QOL analysis of baseline was homogeneous between the experimental and control groups. Three months after the rehabilitation process, the experimental group demonstrated an increase in the general QOL functional scales and a decrease of symptom scales compared to the control group. These changes were statistically significant in the functional scales of global health (P<0.01), physical function (P<0.01), role function (P<0.01), emotional function (P<0.05), symptom scales of fatigue (P<0.01) and appetite loss (P=0.001). Six months after the intervention, the outcome was the same as 3 months after the intervention in functional scale domains. However, in the symptom scales, the symptoms in the experimental group were improved compared to the control group. The domains had been significant in the scales of fatigue (P<0.001), dyspnea (P<0.001), pain (P<0.001), insomnia (P<0.001), appetite loss (P<0.001) and constipation (P<0.001). Therefore, the two groups demonstrated a statistically significant difference in 10 domains. In addition, the experimental group demonstrated a significant recovery. In conclusion, systematic rehabilitation programs may be beneficial for lung cancer patients by reducing respiratory symptoms, pain, and improving health-related QOL. Consequently, the findings of this study suggest that systematic rehabilitation programs, prepared by taking into consideration the individual requirements of lung cancer patients, should be incorporated into lung cancer treatment.

Keywords: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire version 3.0; lung cancer; quality of life; systematic rehabilitation programs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Outcomes of (A) global, (B) physical, (C) role, (D) emotional, (E) cognitive and (F) social difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown. Outcomes of (G) fatigue, (H) nausea/vomoting, (I) pain, (J) dyspnea, (K) insomnia and (L) appetite loss difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown. Outcomes of (M) constipation, (N) diarrhea and (O) finacial difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown.
Figure 1
Figure 1
Outcomes of (A) global, (B) physical, (C) role, (D) emotional, (E) cognitive and (F) social difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown. Outcomes of (G) fatigue, (H) nausea/vomoting, (I) pain, (J) dyspnea, (K) insomnia and (L) appetite loss difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown. Outcomes of (M) constipation, (N) diarrhea and (O) finacial difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown.
Figure 1
Figure 1
Outcomes of (A) global, (B) physical, (C) role, (D) emotional, (E) cognitive and (F) social difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown. Outcomes of (G) fatigue, (H) nausea/vomoting, (I) pain, (J) dyspnea, (K) insomnia and (L) appetite loss difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown. Outcomes of (M) constipation, (N) diarrhea and (O) finacial difficulties of EORTC QLQ-C30 scales at different time points in the two groups are shown.

Similar articles

Cited by

References

    1. Becerra M, John G, Drepper M, et al. Hospital-based internal medicine: a review of 2011. Rev Med Suisse. 2012;8:259–263. (In French). - PubMed
    1. Carr LL, Finigan JH, Kern JA. Evaluation and treatment of patients with non-small cell lung cancer. Med Clin North Am. 2011;95:1041–1054. - PubMed
    1. Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29:89–96. - PubMed
    1. Soo RA, Kawaguchi T, Loh M, et al. Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy. Future Oncol. 2012;8:451–462. - PubMed
    1. Sloan JA, Zhao X, Novotny PJ, et al. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol. 2012;30:1498–1504. - PMC - PubMed

LinkOut - more resources